ArticlePublic health in practice (Oxford, England)2026
A short version of the post-COVID-19 condition stigma questionnaire.
Article in Public health in practice (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blood-Brain Barrier Changes and Related Microvascular Outcomes in Long-COVID: A Comprehensive Review.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The purpose of this study was to develop a short version of the 40-item Post-COVID-19 Condition Stigma Questionnaire (PCCSQ) while preserving its factor structure, reliability, and validity. The PCCSQ is a sound tool for assessing the discrimination experienced by people with a diagnosis of long covid, but a shorter version would be less demanding of respondents experiencing fatigue and brain fog and easier for clinicians and researchers to administer. Study design: This was an observational study. Methods: From the original 40-items measuring the 6-factor construct Results: The 12-item instrument maintains the 6-factor structure of long covid stigma, has a mean discrimination index of 0.40 (sd = 0.08; range 0.22-0.48), an internal consistency of α = 0.89, a split-half reliability of 0.86, and it correlates predictably with theoretically-related variables. Conclusions: The PCCSQ-12 is a feasible, reliable and valid means of assessing patients' experience of long covid stigma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.